Vučković J, Pajič T, Kušec R, Grat M, Lorbek M, Rogulj D, Pavlič R, Žuran I. Clinical meaning of JAK2 V617F mutation in chronic myeloproliferative disorders – the first experience. TEST ZdravVestn [Internet]. 1 [cited 5Aug.2024];75(10). Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/2034